Susquehanna International Group, LLP En V Veno Medical Corp Call Options Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$3.24 - $6.19 $151,956 - $290,311	-46,900 Reduced 76.76%	14,200 $47,000
Q2 2024 Aug 15, 2024	SELL	$4.62 - $5.5 $757,218 - $901,450	-163,900 Reduced 72.84%	61,100 $320,000
Q1 2024 May 07, 2024	BUY	$3.94 - $6.65 $486,590 - $821,275	123,500 Added 121.67%	225,000 $1.22 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.73 $7,266 - $12,033	2,100 Added 2.11%	101,500 $521,000
Q3 2023 Nov 14, 2023	BUY	$3.16 - $5.74 $314,104 - $570,556	99,400 New	99,400 $535,000
Q4 2022 Feb 14, 2023	SELL	$4.54 - $6.6 $963,388 - $1.4 Million	-212,200 Reduced 89.39%	25,200 $128,000
Q3 2022 Nov 14, 2022	SELL	$0.1 - $7.82 $3,780 - $295,596	-37,800 Reduced 13.74%	237,400 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$3.39 - $6.5 $80,004 - $153,400	23,600 Added 9.38%	275,200 $1.04 Million
Q1 2022 May 16, 2022	BUY	$4.42 - $7.0 $85,748 - $135,800	19,400 Added 8.35%	251,600 $1.6 Million
Q4 2021 Feb 14, 2022	BUY	$6.23 - $10.24 $1.45 Million - $2.38 Million	232,200 New	232,200 $1.53 Million

5.61M

89.3K

5.2K

Ticker NVNO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,469,850
Market Cap $24.6M
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.